EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic Impact of Pelvic Lymph Node Count in Surgically Staged Endometrial Cancer

Yakup Yalcin iD, Kemal Ozerkan iD

Medicina · 2026

DOI: 10.3390/medicina62020399 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicina, 2026. Verfasst von Yakup Yalcin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, School of Medicine, Bursa Uludag University, Bursa 16110, Turkey. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Lymph Nodes. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: The prognostic significance of pelvic lymph node (PLN) count in surgically staged endometrial cancer remains controversial. This study aimed to evaluate the impact of PLN count on overall survival (OS), disease-free survival (DFS), and recurrence patterns in a large cohort of patients with endometrial cancer. Materials and Methods: This retrospective cohort study included 560 patients with endometrial cancer who underwent total hysterectomy, bilateral salpingo-oophorectomy, and pelvic and/or para-aortic lymph node assessment between January 2005 and May 2025 at a tertiary referral center. Patients were stratified according to the number of harvested pelvic lymph nodes (≤20 vs. >20). Clinicopathological characteristics, adjuvant treatments, recurrence patterns, and survival outcomes were analyzed. Survival analyses were performed using Kaplan–Meier estimates and Cox proportional hazards regression models.

Results

Of the 560 patients, 262 (46.8%) had ≤20 pelvic lymph nodes harvested and 298 (53.2%) had >20. The median follow-up duration was 64.5 months. Patients with >20 pelvic lymph nodes had larger tumors, higher FIGO stage, and more frequent para-aortic lymphadenectomy. In multivariate analysis, age, non-endometrioid histology, advanced FIGO stage, tumor grade, and lymphatic metastasis were independently associated with both OS and DFS. Pelvic lymph node count was not independently associated with OS or DFS. Overall recurrence rates were similar between groups; however, recurrence patterns differed significantly, with distant recurrences more frequent in the ≤20 PLN group and local recurrences more common in the >20 PLN group.

Conclusions

In surgically staged endometrial cancer, a higher pelvic lymph node count (>20 nodes) was not independently associated with survival or recurrence outcomes after adjustment for established prognostic factors, although recurrence patterns differed between groups. Survival was primarily determined by age, histologic subtype, FIGO stage, tumor grade, and lymphatic metastasis. Pelvic lymph node count appears to reflect surgical staging intensity and intraoperative risk assessment rather than serving as an independent determinant of prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsLymph NodesFemaleHumansRetrospective StudiesPrognosisAgedMiddle AgedNeoplasm StagingLymphatic MetastasisPelvisLymph Node ExcisionDisease-Free SurvivalCohort StudiesNeoplasm Recurrence, LocalKaplan-Meier EstimateProportional Hazards ModelsAdultHysterectomy

Stichwörter der Autor:innen

endometrial cancerlymph node countpelvic lymphadenectomyrecurrencesurvival

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, School of Medicine, Bursa Uludag University, Bursa 16110, Turkey.

ORCID-Profile: Yakup Yalcin, Kemal Ozerkan

Zitieren

APA

Yalcin, Y., & Ozerkan, K. (2026). Prognostic Impact of Pelvic Lymph Node Count in Surgically Staged Endometrial Cancer. Medicina. https://doi.org/10.3390/medicina62020399

Vancouver

Yalcin Y, Ozerkan K. Prognostic Impact of Pelvic Lymph Node Count in Surgically Staged Endometrial Cancer. Medicina. 2026. doi:10.3390/medicina62020399

BibTeX
@article{Yalcin2026,
  author = {Yalcin, Yakup and Ozerkan, Kemal},
  title = {Prognostic Impact of Pelvic Lymph Node Count in Surgically Staged Endometrial Cancer},
  journal = {Medicina},
  year = {2026},
  doi = {10.3390/medicina62020399}
}
Kostenlos starten →